|
|
World Microfluidics / Lab-on-a-Chip MarketsPublished by: Frost & Sullivan Published: Jan. 21, 2003 Table of Contents 1 Executive Summary 2 Total Analysis of the Microfluidics / Lab-on-a-Chip Markets 3 Market Challenges and Market Engineering Strategy for the Microfluidics / Lab-on-a-Chip Markets 4 Microfluidics Market Engineering Awards for the Microfluidics / Lab-on-a-Chip Markets 5 Key Industry Participants AbstractProgressive Technologies Empower Growth of the Nascent MarketContinuous technological advancements in micro-electromechanical systems and semiconductor micro-fabrication methods, along with the prolific growth of plastics/polymer science, biosensors, and biomedical engineering, are aiding the development of microfluidics technologies globally. With the influx of genomic, proteomic, and other biological data, lab-on-a-chip products will continue to provide superior benefits in many vertical markets including pharmaceuticals, biotechnology, life science, defense, public health, and food/agriculture. This Frost & Sullivan research examines the World Microfluidics/Lab-on-a-chip Markets and its broad areas of application including DNA/RNA, microorganism detection, protein, high-throughput screening, ADME/T, and cell/tissue. The report also provides valuable information on intellectual property rights, regulatory environment, and emerging technologies/applications that will aid companies in identifying growth prospects. Government Funding, Nanotechnology Initiatives, and Miniaturization Lead to Sustained Expansion "A substantial increase in funding from various government agencies such as the National Institutes of Health and the Department of Defense in the United States are ensuring steady revenues for market participants", says the analyst. With venture capital becoming scarce and the majority of vendors still moving toward mainstream status, the bio-warfare requirements and nanotechnology initiatives of governments are offering several market opportunities. The availability of partial or complete genomes and new therapies are enabling fresh analyses in research applications and diagnostics, increasing the demand for microfluidics devices. The analyst adds, "Miniaturized products that facilitate cost savings with low consumption of reagents, lesser amplification requirements, and reduction in sample preparation, are assisting market expansion. High-throughput labs are upgrading to lab-on-a-chip technology that eliminates process bottlenecks, thereby stepping up market acceptance." Strategic Alliances, Long-term Focus, Awareness Creation - The Recipe for Successful Commercialization Automation and instrument manufacturers are introducing improved products that have convergence features, robotics and liquid handling capabilities, as well as compatibility with higher density microplates. This is impeding the growth of the microfluidics market. Cost containment and a slow adoption rate because of the sluggish economy, intellectual property (IP) litigations due to overlapping applications, as well as political and legal regulations are also retarding growth.
As challenges increase, focus on strategic partnerships or acquisitions are providing market stability by plugging gaps in technology, IP rights, and distribution channels. Application-driven products to meet current market needs, cross-licensing agreements, fund allocation for longer, high-risk projects such as microorganism detection, and enhancement of end-user knowledge are likely to maximize market prospects. The trend toward highly integrated, modular microfluidics technologies that favor multiplexing at competitive prices is expected to drive the future market.
|
|
|||
|
About MarketResearch.com
|
||||